[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"symptom-monitoring\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:symptom-monitoring":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,53],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":32,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":41,"lastUpdatePostDateStruct":42,"startDateStruct":45,"completionDateStruct":47,"leadSponsor":49,"locationsCount":52},"100618496","mhealth-intervention-for-pain-self-management-100618496",false,"NCT07332377","mHealth Intervention for Pain Self Management","PsyMINT: Mobile Health (mHealth) Intervention to Support Self-Management of Pain and Symptoms for Cancer Survivors","PsyMINT","Inclusion Criteria:\n\n* In a post-treatment stage with no evidence of disease (complete remission)\n* Diagnosed with cancer in the past three years\n* Experiencing cancer\u002Ftreatment-related pain\n* ≥ 18 years of age at the time of first diagnosis\n* Cognitively able to actively participate in an online-based study\n* Able to read, write, and understand English\n\nExclusion Criteria:\n\n* Individuals who currently use any medication for psychiatric reasons (including stimulants, and mood stabilizers)\n* Patients with major psychotic disorders (bipolar disorder or schizophrenia) and\u002For substance use disorders.\n* Those who are currently pregnant or plan to become pregnant in the next three months","ALL","18 Years",{"count":20,"type":21},25,"ESTIMATED","INTERVENTIONAL",[24],"NA","This is a feasibility pilot test of a single-arm intervention to evaluate the beta version of an mHealth app-based behavioral intervention prior to scaling for a randomized controlled trial (RCT). This mHealth intervention is designed to enhance self-efficacy and support pain and symptom self-management among post-treatment cancer survivors.",[27,28,29,30,31],"Pain","Pain Management","Symptom Monitoring","Symptom Management","Cancer Survivorship",[33,34,35,36,37,38,39],"cancer survivorship","pain management","mHealth","behavioral intervention","nonpharmacologic intervention","app","digital health","RECRUITING","2026-03-16",{"date":43,"type":44},"2026-03-18","ACTUAL",{"date":46,"type":44},"2026-02-23",{"date":48,"type":21},"2027-03-31",{"name":50,"class":51},"Virginia Commonwealth University","OTHER",1,{"id":54,"slug":55,"hasResults":11,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":59,"eligibilityCriteria":60,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":61,"targetDuration":4,"studyType":22,"phases":63,"briefSummary":64,"conditions":65,"keywords":69,"overallStatus":74,"whyStopped":4,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":4},"100548673","mitigating-toxicity-by-electronic-health-portal-mediated-interactive-monitoring-of-patient-reported-side-effects-100548673","NCT06424054","Mitigating Toxicity by Electronic Health Portal-mediated Interactive Monitoring of Patient-reported Side Effects","Mitigating Toxicity of (Neo)Adjuvant Chemotherapy by Applying Electronic Health Portal-mediated Interactive Monitoring of Patient-reported Side Effects: the Prospective Randomized eChemoCoach Trial","eChemoCoach","Inclusion Criteria:\n\n* \\- Starting (neo)adjuvant treatment with chemotherapy for breast cancer according to one of the below mentioned treatment protocols:\n\n  * Four cycles of doxorubicin 60mg\u002Fm2 and cyclophosphamide 600mg\u002Fm2 (AC) dose dense q 2 weeks, followed by twelve cycles of weekly paclitaxel 80mg\u002Fm2 (also in combination with carboplatin AUC6 q 3 weeks)\n  * Nine cycles q 3 weeks of paclitaxel 80mg\u002Fm2 on day 1 and 8, carboplatin AUC 3 on day 1 and 8, trastuzumab 8mg\u002Fkg loading dose (followed by doses of 6mg\u002Fm2 at subsequent cycles) on day1 and pertuzumab loading dose of 840mg (followed by doses of 420mg at subsequent cycles) on day 1\n* Age ≥ 18 years\n* WHO PS ≤1\n* Capable of using the EHP or get help in case of low (e-)health literacy. This includes being capable of login using DigiD, a system used by the Dutch government to verify the identity of a person\n* Being able to read or get help from a relative in case of illiteracy\n\nExclusion Criteria:\n\n* \\- Participation in a trial with an investigational product (because more frequent and structured symptom reporting is performed in these studies).\n* Patients who have been treated with chemotherapy in the past (since these patients are at higher risk for developing side effects of current chemotherapy).\n* Patients that already started with their chemotherapy cycle",{"count":62,"type":21},746,[24],"Chemotherapy induces side effects varying in severity, impacting patients' quality of life and necessitating unplanned hospital care. Patient-reported outcomes (PROs) could aid in early detection and management of side effects. However, existing PRO monitoring lacks triage capabilities, leading to clinician involvement and suboptimal symptom management. The investigators propose eChemoCoach, an electronic questionnaire integrated into the electronic health portal, offering real-time symptom assessment and personalized advice based on CTCAE criteria. Our study aims to assess the impact of eChemoCoach on non-hematological CTCAE ≥ 3 graded side effects in early breast cancer patients undergoing chemotherapy. This is a randomized controlled trial involving 746 patients that will evaluate the eChemoCoach's efficacy compared to standard monitoring. Phase one will validate questionnaires and assess usability, while phase two focuses on the primary outcome. Te investigators anticipate reduced severe side effects, thereby enhancing patients' quality of life, reducing stress, and minimizing hospital visits.",[66,67,29,68],"Breast Cancer","eHealth","Self Management",[66,70,71,67,72,73],"remote monitoring","emonitoring","symptom management","symptom monitoring","NOT_YET_RECRUITING","2024-05-16",{"date":77,"type":44},"2024-05-21",{"date":79,"type":21},"2025-06-01",{"date":81,"type":21},"2029-12-01",{"name":83,"class":51},"Noordwest Ziekenhuisgroep"]